MedTrace Logo

Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients

NCT03626896 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2019-06-21

No results posted yet for this study

Summary

This study is to evaluate the safety and find the tolerated ultrasound dose of transient opening of the blood-brain barrier (BBB) by using the NaviFUS System in recurrent GBM patients.

Conditions

Interventions

DEVICE

NaviFUS System

BBB Disruption by FUS in recurrent GBM Other Name: Neuronavigation-guided focus ultrasound system

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    collaborator OTHER

  • NaviFUS Corporation

    lead INDUSTRY

Principal Investigators

  • Kuo-Chen Wei, M.D. · Chang Gung Memorial Hospital

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-17
Primary Completion
2019-05-20
Completion
2019-06-19

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03626896 on ClinicalTrials.gov